Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JONATHAN B KING

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1174023352
CMS profile
10822739
Location
TYLER, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$17,335.67

81 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

Page 2 of 2; records 51–81 of 81 matching records. This page contains 31 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JONATHAN B KING

NPI 1174023352 · CMS profile ID 10822739

Physician Assistants & Advanced Practice Nursing Providers / Nurse Practitioner / Family

TYLER, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–81 of 81 matching records. This page contains 31 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1174023352?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JONATHAN B KING, NPI 1174023352, CMS profile ID 10822739. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–81 of 81 matching records. This page contains 31 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1174023352?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). JONATHAN B KING, NPI 1174023352, CMS profile ID 10822739. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–81 of 81 matching records. This page contains 31 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1174023352?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
JONATHAN B KING, NPI 1174023352, CMS profile ID 10822739, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–81 of 81 matching records. This page contains 31 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1174023352?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

81 matching records · $17,335.67 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 81 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–81 of 81.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Genentech USA, Inc. $40.2005/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040655553 CMS
Genentech USA, Inc. $33.7005/24/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040655563 CMS
Myriad Genetic Laboratories, Inc. $9.1305/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059808075 CMS
Regeneron Healthcare Solutions, Inc. $3.7905/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999743415 CMS
Regeneron Healthcare Solutions, Inc. $18.6205/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999743407 CMS
Apellis Pharmaceuticals, Inc. $15.2005/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056343373 CMS
Seagen Inc. $24.4805/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995639841 CMS
GENZYME CORPORATION $38.6505/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050400535 CMS
Bayer Healthcare Pharmaceuticals Inc. $27.3205/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1005606503 CMS
Celgene Corporation $14.4405/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016317763 CMS
Myriad Genetic Laboratories, Inc. $90.2304/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059808073 CMS
Stemline Therapeutics Inc. $26.5504/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040048239 CMS
Myriad Genetic Laboratories, Inc. $27.2204/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059808071 CMS
Myriad Genetic Laboratories, Inc. $15.9104/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059808069 CMS
Regeneron Healthcare Solutions, Inc. $6.0004/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999743399 CMS
Regeneron Healthcare Solutions, Inc. $6.3304/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999743391 CMS
Genentech USA, Inc. $1,250.0004/06/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040655507 CMS
Genentech USA, Inc. $91.8804/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040655515 CMS
Lilly USA, LLC $14.6203/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032962243 CMS
Regeneron Healthcare Solutions, Inc. $5.8102/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999743375 CMS
Regeneron Healthcare Solutions, Inc. $20.3102/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999743383 CMS
Mirati Therapeutics, Inc. $21.9102/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058012233 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $99.7002/15/2023 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993429209 CMS
Myriad Genetic Laboratories, Inc. $25.2802/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059808067 CMS
Sumitomo Pharma America, Inc. $29.5902/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031116519 CMS
Lilly USA, LLC $109.8102/02/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1033038659 CMS
Janssen Biotech, Inc. $9.4801/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988429627 CMS
AVEO Pharmaceuticals, Inc. $17.5601/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049071295 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $99.7001/14/2023 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 993429205 CMS
Lilly USA, LLC $13.6101/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1033114535 CMS
Regeneron Healthcare Solutions, Inc. $90.6801/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999743367 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $6,141.32 32
PY2022 $46,162.52 90
PY2023 $17,335.67 81
PY2024 $11,836.09 113
PY2025 $15,743.22 129

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Recipient $2,489.12 13

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

13 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient Regeneron Pharmaceuticals, Inc. $38.84 04/10/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398716
Recipient Regeneron Pharmaceuticals, Inc. $55.00 04/10/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398718
Recipient Regeneron Pharmaceuticals, Inc. $162.14 04/10/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398720
Recipient Regeneron Pharmaceuticals, Inc. $316.71 03/22/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398712
Recipient Regeneron Pharmaceuticals, Inc. $603.22 03/22/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398714
Recipient Regeneron Pharmaceuticals, Inc. $21.86 03/21/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398700
Recipient Regeneron Pharmaceuticals, Inc. $31.15 03/21/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398702
Recipient Regeneron Pharmaceuticals, Inc. $43.47 03/21/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398704
Recipient Regeneron Pharmaceuticals, Inc. $62.30 03/21/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398706
Recipient Regeneron Pharmaceuticals, Inc. $77.56 03/21/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398708
Recipient Regeneron Pharmaceuticals, Inc. $130.74 03/21/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398710
Recipient Regeneron Pharmaceuticals, Inc. $134.92 03/20/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398698
Recipient Regeneron Pharmaceuticals, Inc. $811.21 02/26/2024 Covered Recipient Non-Physician Practitioner A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY VERSUS INVESTIGATOR'S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1) No dispute reported 06/30/2026 1082398696